HYLATOPICPLUS LOTION Rx
Generic Name and Formulations:
Water, glycerin, ethylhexyl palmitate, propylene glycol, cetearyl alcohol, theobroma grandiflorum seed butter, dicetyl phosphate, dimethicone, petrolatum, tocopheryl acetate, steareth-10, phenoxyethanol, ceteareth-10 phosphate, hydroxypropyl bispalmitamide MEA (ceramide), disodium EDTA, sodium hyaluronate and sodium hydroxide; lotion.
Encore Dermatology, Inc.
Indications for HYLATOPICPLUS LOTION:
Dermatitis (including radiation dermatitis). Dry skin.
Adults and Children:
Apply and massage into affected area 3 times daily or as needed. Broken skin: may be occluded.
Avoid eyes and exposure to sun. Treatment may be continued during antiinfective therapy. Reevaluate if no improvement after 10–14 days.
Radiation therapy: may dissolve fuchsin dye; do not use 4 hours prior to session.
Foam—100g, 150g; Crm—100g, 450g, Lotion—14oz
Endocrinology Advisor Articles
- Higher BUN May Increase Risk for Incident Diabetes
- Efficacy of Novel GLP-1 Receptor Agonist Drug Device Examined
- Takeout Food May Increase Adverse Health Consequences in Children
- Nonhormonal Options Available for Menopause Symptom Relief
- Plasma Volume Changes Mediate Risk of CV Mortality With Empagliflozin
- New Consensus Recommendations on Use of Continuous Glucose Monitoring
- Does Genetic Susceptibility Lead to Late-Onset Type 1 Diabetes?
- Clinical Outcomes in T2D: Low-Carbohydrate vs Calorie-Restricted Diet
- New Continuous Glucose Monitoring System Now Available for Medicare Patients
- Text Message-Delivered Interventions Effective for Weight Management
- Effect of Intra-Articular Depot Betamethasone on Insulin Resistance in T2D
- Gastric Bypass vs Sleeve Gastrectomy Outcomes in Morbid Obesity
- Acute Kidney Injury Increases Risk for Postdischarge Hypoglycemia in Diabetes
- Novel Deep Learning System May Help Identify Diabetic Retinopathy
- Trends in CVD, Risk Factors, and Medications in Children With T1D